News Daily News Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients Todd Neale September 12, 2025
News Conference News ESC Heart Failure 2025 HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM Todd Neale May 19, 2025
News Daily News Acoramidis Approved in Europe for ATTR Cardiomyopathy Michael O'Riordan February 12, 2025
News Daily News FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy L.A. McKeown November 25, 2024
News Conference News ESC 2024 HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM L.A. McKeown August 30, 2024
News Daily News FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy L.A. McKeown October 10, 2023
News Conference News ESC Heart Failure 2023 Amyloid Removal Looks Possible in ATTR Cardiomyopathy Imaging Trial Shelley Wood May 23, 2023
News Daily News As Amyloidosis Field Explodes, Physicians Need to Spot and Treat Todd Neale October 20, 2021